“drugs” Archives

in
Entry Author Date Location
War Paint to Bone Paint: MIT Spinout Aims to Transform Regenerative Meds 04/21/20 Boston
Japan’s Kyowa Kirin Pays MEI Pharma $100M in Blood Cancer Drug Pact 04/14/20 National
Creating Consistent Value in Biotech Without Diluting Stakeholders 04/07/20 National
Vir Advances Antibodies Against COVID-19, CEO Leads BIO’s Coronavirus Outreach 04/02/20 National
Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus 03/31/20 Europe
Axsome Plans to Try Again After Failure in Treatment-Resistant Depression 03/30/20 New York
Lax Approval Requirements Yield Blockbusters That Don’t Work 03/13/20 National
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System 02/25/20 Europe
New Meds Set to Reshape US CNS and Oncology Markets 02/18/20 National
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019 02/12/20 National
UK Startups Double in Number Backed By Larger Scale Investments: Report 01/09/20 Europe
The Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It? 10/10/19 National
Five Years After Y Combinator First Admits Biotechs, They’re Dug In 10/09/19 San Francisco
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels 10/07/19 National
Akcea, Fresh Off C-Suite Shakeup, Dishes Heart Drug to Pfizer for $250M 10/07/19 Boston
Bio Roundup: PARP Progress, A New Commish, IPO-Palooza & More 10/04/19 National
Meissa Scores $30M to Test Vaccine for Dangerous Respiratory Virus 09/26/19 San Francisco
Enanta Steps Forward in NASH Race, With Unclear Prospects 09/26/19 Boston
Drug Pricing: Innovation, Investment, and the Public Good 09/24/19 Boston
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More 09/13/19 National
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards 09/10/19 National
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss 09/03/19 Boston
Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails 08/22/19 San Diego
FDA Rejects Sarepta’s Second Duchenne Drug, Citing Safety Concerns 08/19/19 Boston
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work 08/08/19 Boston
Women’s Health-Focused Luca Bio Takes Microbiome R&D Beyond the Gut 08/06/19 Boston
Another Delay for Intra-Cellular as FDA Extends Review of Psych Drug 08/05/19 New York
GlycoMimetics Sickle Cell Drug Flops as Others Creep Forward 08/05/19 New York
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston 07/31/19 National
Page 1 of 105 next page »